Publications
Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.
If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed.
Already granted access to an article?
If you cannot find the article you are looking for please contact Probity Medical Research.
Journals, Articles and Presentations
Articles by Publication Year
Association of the Number of Cardiovascular Risk Factors with Disease Severity. Exploratory Analysis of Baseline Data from the Canadian Randomized Study to Evaluate the EfFicacy and Safety of Etanercept Plus as Needed Topical Agent vs Etanercept Alone in Patients with Moderate-to-Severe Plaque Psoriasis (REFINE)
Presented at Canadian Dermatology Association (CDA) 88th Annual Conference, Quebec City, Quebec, Canada, Jun 27-30, 2013
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from five years of follow-up
British Journal of Dermatology 2013 Jan 10. doi: 10.1111/bjd.12214. [Epub ahead of print]
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
British Journal of Dermatology 2013 Feb;168(2):412-421. doi: 10.1111/bjd.12110. Epub 2013 Jan 18.
Efficacy and Safety of Topical Janus Kinase (JAK) Inhibitor Tofacitinib in the Treatment of Chronic Plaque Psoriasis: Results of a Phase 2a Randomized Clinical Trial
Presented at the 71st Annual American Academy of Dermatology Meeting, Miami Beach, Florida, USA, March 1-5, 2013
Apremilast Improves Pruritus in Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2b, Randomized, Controlled Study
Presented at the 71st Annual American Academy of Dermatology Meeting, Miami Beach, Florida, USA, March 1-5, 2013
Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Moderate to Severe Psoriasis: 16-Week Results of a Phase 3, Randomized, Controlled Trial (ESTEEM 1)
Presented at the 71st Annual American Academy of Dermatology Meeting, Miami Beach, Florida, USA, March 1-5, 2013
Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab
Annals of the Rheumatic Diseases 2013 Jan;72(1):83-8. doi: 10.1136/annrheumdis-2012-201697. Epub 2012 Sep 12.
Improvement of Psoriasis in Subjects With and Without Prior Brodalumab (AMG 827) Treatment in an Open-Label Extension Study
Presented at the 71st Annual American Academy of Dermatology Meeting, Miami Beach, Florida, USA, March 1-5, 2013
What's Your Diagnosis? Boy With Pruritic Rash on Both Cheeks
Consultant for Pediatricians 2013 Jan;12(1):20-23.
What's Your Diagnosis? Boy With Rash on Forefeet
Consultant for Pediatricians 2013 Apr;12(4):172-175.
About PMR | Investigators | Experience | Locations | News | Publications | Privacy Policy | Contact | Sitemap |
Copyright 2014 Probity Medical Research Inc. All Rights Reserved.